HIV-Associated TB in An Giang Province, Vietnam, 2001–2004: Epidemiology and TB Treatment Outcomes by Thuy, Trinh Thanh et al.
HIV-Associated TB in An Giang Province, Vietnam, 2001–
2004: Epidemiology and TB Treatment Outcomes
Trinh Thanh Thuy
1, N. Sarita Shah
2, Mai Hoang Anh
3, Do Trong Nghia
4, Duong Thom
3, Truong Linh
3, Dinh Ngoc Sy
4, Bui Duc Duong
4, Luu Thi
Minh Chau
5, Phung Thi Phuong Mai
5, Charles D. Wells
2, Kayla F. Laserson
2, Jay K. Varma
2,6*
1Global AIDS Program, U.S. Centers for Disease Control and Prevention, Hanoi, Vietnam, 2Division of Tuberculosis Elimination, U.S. Centers for
Disease Control and Prevention, Atlanta, Georgia, United States of America, 3An Giang Province Preventive Medical Center, Long Xuyen City,
Vietnam, 4National Hospital of Tuberculosis and Lung Diseases, Vietnam National TB Program, Ministry of Health, Hanoi, Vietnam, 5LIFE-GAP Office,
Ministry of Health, Hanoi, Vietnam, 6Thailand Ministry of Public Health – U.S. Centers for Disease Control Collaboration, Bangkok, Thailand
Background. Mortality is high in HIV-infected TB patients, but few studies from Southeast Asia have documented the benefits
of interventions, such as co-trimoxazole (CTX), in reducing mortality during TB treatment. To help guide policy in Vietnam, we
studied the epidemiology of HIV-associated TB in one province and examined factors associated with outcomes, including the
impact of CTX use. Methodology/Principal Findings. We retrospectively abstracted data for all HIV-infected persons
diagnosed with TB from 2001–2004 in An Giang, a province in southern Vietnam in which TB patients receive HIV counseling
and testing. We used standard WHO definitions to classify TB treatment outcomes. We conducted multivariate analysis to
identify risk factors for the composite outcome of death, default, or treatment failure during TB treatment. From 2001–2004,
637 HIV-infected TB patients were diagnosed in An Giang. Of these, 501 (79%) were male, 321 (50%) were aged 25–34 years,
and the most common self-reported HIV risk factor was sex with a commercial sex worker in 221 (35%). TB was classified as
smear-positive in 531 (83%). During TB treatment, 167 (26%) patients died, 9 (1%) defaulted, and 6 (1%) failed treatment. Of
454 patients who took CTX, 116 (26%) had an unsuccessful outcome compared with 33 (70%) of 47 patients who did not take
CTX (relative risk, 0.4; 95% confidence interval [CI], 0.3–0.5). Adjusting for male sex, rural residence, TB smear status and
disease location, and the occurrence of adverse events during TB treatment in multivariate analysis, the benefit of CTX
persisted (adjusted odds ratio for unsuccessful outcome 0.1; CI, 0.1–0.3). Conclusions/Significance. In An Giang, Vietnam,
HIV-associated TB was associated with poor TB treatment outcomes. Outcomes were significantly better in those taking CTX.
This finding suggests that Vietnam should consider applying WHO recommendations to prescribe CTX to all HIV-infected TB
patients.
Citation: Thuy TT, Shah NS, Anh MH, Nghia DT, Thom D, et al (2007) HIV-Associated TB in An Giang Province, Vietnam, 2001–2004: Epidemiology and
TB Treatment Outcomes. PLoS ONE 2(6): e507. doi:10.1371/journal.pone.0000507
INTRODUCTION
HIV has contributed to a global resurgence of tuberculosis
(TB).[1] Despite successful implementation of World Health
Organization (WHO)-recommended TB control strategies, many
high-burden TB countries have seen stable or rising TB case
notifications due to HIV-associated TB.[2] HIV fuels the TB
epidemic in several ways. HIV-infected persons have a 50%
lifetime risk of progressing from latent TB infection to TB disease,
compared with 5–10% of HIV-uninfected persons.[1] HIV-
infected persons are more likely than HIV-uninfected persons to
have acid-fast bacilli (AFB) smear-negative sputum results, with up
to 60% having negative sputum smears.[3] This may delay
diagnosis and treatment of TB, potentially leading to greater TB
transmission and mortality. Compared with HIV-uninfected TB
patients, HIV-infected TB patients have substantially higher case
fatality rates, which can be reduced through co-trimoxazole (CTX)
and anti-retroviral therapy (ART).[4–7]
Vietnam ranks 13
th among the 22 countries designated by
WHO as having the world’s highest TB burden.[2] Vietnam was
one of the first of these countries to reach WHO targets for
successful DOTS implementation, including .70% case detection
and .85% cure for new, smear-positive TB cases. Nevertheless,
case notifications have been rising in Vietnam, and HIV is likely
an important cause.[2] Vietnam’s HIV epidemic is concentrated
in urban areas of several provinces and high-risk populations, e.g.
injection drug users, commercial sex workers, and clients of
commercial sex workers. Overall, UNAIDS estimates that 260,000
HIV-infected people were living in Vietnam in 2005, including an
estimated 0.5% of the population aged 15–49 years.[8] In 2005,
HIV-associated TB accounted for approximately 4.3% of all TB
cases nationally and as many as 9.8% of cases in Ho Chi Minh
City in 2005. (Vietnam Ministry of Health, unpublished)
In Vietnam, HIV-infected TB patients have a high mortality
rate, but limited information is known about risk factors for death.
One study from Ho Chi Minh City examined the relationship
between HIV, anti-TB drug-resistance, and TB treatment out-
comes in 2196 TB patients registered from 1998–2000.[9] This
study found that the mortality rate for HIV-infected, smear-
positive TB patients was 34%, compared with 3% in HIV-
uninfected patients. This study only examined outcomes for a small
number of HIV patients (44 total) and did not analyze factors
associated with poor treatment outcomes in HIV-infected TB
patients.
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PLoS ONE | www.plosone.org 1 June 2007 | Issue 6 | e507An Giang province (2005 population 2,194,218) has the highest
provincial TB notification rate in Vietnam (252 cases per 100,000
in 2004), and the fifth highest HIV prevalence (0.6%).(Vietnam
Ministry of Health, unpublished) Unlike most provinces in
Vietnam, TB patients in An Giang routinely receive HIV
counseling and testing and HIV patients are screened regularly
by chest radiography for TB.(Vietnam Ministry of Health,
unpublished) In 2004, HIV prevalence in TB patients was 4.8%.
We conducted an evaluation of TB and HIV collaboration in An
Giang province to help guide policies and strategies for scaling up
TB/HIV collaboration in Vietnam. As part of this larger
evaluation, we conducted a retrospective cohort study of all
HIV-infected TB patients diagnosed in An Giang province from
2001–2004 in order to improve our understanding of the local
epidemiology and to identify factors associated with TB treatment
outcomes.
METHODS
Diagnosis of TB and HIV in An Giang
In An Giang, persons suspected of having TB are referred to TB
clinics at district health centers or to the TB clinic at the provincial
hospital for a standardized evaluation, including history and
physical examination, examination of three sputum specimens for
AFB, and, if AFB smear-negative, chest radiography. TB diagnosis
and classification follow standard WHO definitions.[10] All
persons diagnosed with TB in these facilities undergo HIV
counseling and testing. A rapid serological test is performed in the
TB clinic and, if positive, is sent to a central laboratory at the
province’s Preventive Medicine Center [PMC] for repeat HIV
serology. HIV testing in the laboratory is by enzyme-linked
immunosorbent assay (Genscreen, Sanofi, Paris, France or
Serodia, Fujirebio, Tokyo, Japan) followed by two different HIV
ELISA tests if the first is positive. The tests used varied over the
time of this project.
From 2001 – 2004, HIV-infected patients enrolled in An
Giang’s home-based care program were also routinely referred for
chest radiography to screen for pulmonary TB, regardless of
symptoms. In 2004, 61% of 357 HIV-infected persons enrolled in
home-based care received at least one chest radiograph. Patients
with abnormal chest radiographs were referred for further
evaluation at a TB clinic, but 90% did not follow-up with such
referrals.(CDC, unpublished)
In addition to routine clinical records and standardized TB
registers, TB clinics also maintain a separate register of HIV-
infected TB patients. District health centers and An Giang
province maintain clinical records and a register of persons
diagnosed with HIV.
Data Collection
We retrospectively reviewed TB, HIV, and TB/HIV registers and
clinical records to collect data about all HIV-infected TB patients
aged $15 years diagnosed in An Giang province from 2001 to
2004. Data were abstracted from these records using a standard-
ized form that included questions about personal and demograph-
ic history; HIV risk factors, conditions, and treatment; TB
diagnostic studies, treatment history, and treatment outcomes.
Public health staff were trained to complete the abstraction form,
and forms were checked for completeness and accuracy by a data
collection supervisor.
Definitions for Data Analysis
We used standard WHO definitions for TB disease classification,
registration and treatment outcome categories. TB registration
status was divided into ‘‘new,’’ ‘‘re-treatment,’’ or ‘‘transfer in.’’
The ‘‘re-treatment’’ group included cases that were classified as
relapse, treatment after failure, or treatment after default. Final
TB treatment outcome was divided into ‘‘successful’’ or ‘‘un-
successful.’’ A ‘‘successful’’ treatment outcome included cured or
completed; ‘‘unsuccessful’’ included failure, death, or default; three
cases with an outcome of transfer out were excluded.
We divided age into five categories: 15–24 years, 25–34 years,
35–44 years, 45–54 years, and greater than 55 years. We divided
districts into ‘‘urban’’ (Long Xuyen city and Chau Doc district) or
‘‘rural’’ (remaining nine districts).
TB clinical records indicated whether or not the patient suffered
an adverse event during TB treatment. Clinical staff did not use
a standardized definition for recording adverse events, and there
was no supplemental documentation for what adverse event
occurred. Staff reported that this category was most commonly
used to indicate rash or intolerance to anti-TB medications.
HIV/AIDS clinical records collected data about occupation,
education, religion, ethnicity, marital status, and HIV risk group
using pre-specified options. We used these data elements and
response options when collecting data. For analysis, we re-
classified occupation as ‘‘employed’’ or ‘‘unemployed.’’ Persons
were considered ‘‘employed’’ if they held any type of job,
including: farmer, driver, worker (of any type), teacher, soldier/
police, public servant, or unskilled laborer. Persons were
considered ‘‘unemployed’’ if they had no job, were a housewife,
or were only intermittently employed. Education was classified as
secondary or below (including illiterate persons) vs. high school or
above (including college or university). Marital status was classified
as married, single, divorced, separated, and widowed.
HIV risk assessment categories that were pre-defined on public
health forms included: men who have sex with men (MSM), sex
with a commercial sex worker (CSW), sex with a stable partner,
sex with multiple partners, heterosexual sex with spouse, injection
drug user (IDU), HIV-infected mother (i.e., mother-to-child
transmission) or other.
HIV/AIDS clinical records included whether a person had
conditions consistent with HIV at the time of HIV diagnosis,
including weight loss $10%, fever$1 month, diarrhea$1 month,
TB, Candida esophagitis, neurological disorder, recurrent pneu-
monia, invasive cervical cancer, cryptococcal meningitis, Kaposi’s
sarcoma, generalized herpes infection, or other. We divided data
about the presence of HIV symptoms into ‘‘yes’’ if any HIV
symptom was noted (including other write-in symptoms) or ‘‘no.’’
No hematology or immunology laboratory data were available.
HIV/AIDS clinical records also indicated whether the patient
was prescribed co-trimoxazole (CTX). Records did not indicate
the dosage, frequency or duration of CTX and did not indicate
whether the patient actually ingested the drug. An Giang HIV/
AIDS program policy is to provide CTX to all HIV-infected
persons free of charge. Current national policy is to provide CTX
to HIV-infected persons with WHO stage 3 or 4, WHO stage 1 or
2 with CD4+ T-lymphocyte,200 cells/mm
3, or WHO stage 2
with total lymphocyte count,1200 cells/mm
3. CTX is not
routinely provided in TB clinics. ART was not available in An
Giang province during the years covered by this evaluation.
Statistical Analysis
To describe patient characteristics, we calculated proportions and
medians. For categorical variables, we compared proportions
using chi-square tests and, when appropriate, Fisher’s exact test.
For continuous variables, we compared medians using the
Wilcoxon Rank-Sum Test and evaluated trends using chi-squared
TB/HIV in Vietnam
PLoS ONE | www.plosone.org 2 June 2007 | Issue 6 | e507test for trend. Rates were calculated using census data provided by
local government authorities.
We compared HIV-infected TB patients with a successful TB
treatment outcome to those with an unsuccessful outcome. In
bivariate analysis, we analyzed risk factors for an unsuccessful
outcome by age, sex, occupation, education, marital status, HIV
risk group, residence in a rural district, adverse event during TB
treatment, CTX use, prior history of TB, TB types, and
registration status. In multivariate logistic regression analysis, we
selected variables for inclusion based on plausibility, a priori
evidence, completeness of data, or a p-value,=.20 in bivariate
analysis. Variables were also checked for co-linearity and
interactions and model fit assessed with the maximum likelihood
test. Variables included in the final model included sex, the
presence of an adverse event, rural residence, TB smear status and
disease location (smear-positive vs. smear-negative vs. extrapul-
monary), and CTX. We explored the robustness of our findings by
repeating this analysis with all patients missing CTX data being re-
defined as having received CTX and, separately, as having not
received CTX. We also analyzed risk factors when we removed
adverse event from the model and when we changed the outcome
variable from the composite end-point of death, default, or failure
to a composite of death and default or to just death.
Ethical Review
The analyses reported in this manuscript were part of an
evaluation of the TB/HIV program in An Giang province.
CDC and the Vietnam National TB Program determined that this
project represented a public health program evaluation, not
human subjects research, and, therefore, did not require review by
an institutional review board.
RESULTS
Epidemiology of TB/HIV in An Giang
During the study period, An Giang province registered 21,964 TB
patients, 637 (2.9%) of whom were HIV-infected. The number
and proportion of HIV-infected TB patients increased over this
period (139 [2.7%] in 2001, 150 [2.5%] in 2002, 161 [3.0%] in
2003, and 192 [3.5%] in 2004), but the increase was not
statistically significant (p=0.78 for trend). The incidence of
HIV-associated TB per 100,000 persons was higher in urban
areas (10–13 per 100,000) than rural areas (6–8 per 100,000)
(p,.01). Observed incidence increased non-significantly in urban
areas from 2001 (10 per 100,000) to 2003 (13 per 100,000) then
declined slightly in 2004 (12 per 100,000). In rural areas, incidence
Table 1. Demographic characteristics of HIV-infected TB patients (N=637) – An Giang, Vietnam, 2001 – 2004.
..................................................................................................................................................
Characteristic Sub-category n (%)
Sex Male 501 (79)
Female 136 (21)
Age 15–24 67 (11)
25–34 321 (51)
35–44 155 (24)
45–54 71 (11)
55 or older 21 (4)
Missing 2 (,1)
Occupation Farmer 107 (17)
Worker (any type) 50 (8)
Driver 36 (6)
Unemployed 185 (29)
Other (soldier, public servant and scholar) 140 (22)
Missing 119 (19)
Education level Illiterate 76 (12)
Secondary 405 (64)
High School 34 (5)
College or University 2 (,1)
Missing 120 (19)
HIV risk group Sex with commercial sex worker 221 (35)
Sex with stable partner 84 (13)
Injection drug user 67 (11)
Sex with multiple partner 34 (5)
HIV-infected mother 11 (2)
Men having sex with men 3 (,1)
Missing 217 (34)
HIV symptoms at time of HIV diagnosis Yes 514 (81)
No 7 (1)
Missing 116 (18)
doi:10.1371/journal.pone.0000507.t001
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PLoS ONE | www.plosone.org 3 June 2007 | Issue 6 | e507was stable from 2001–2003 (6 per 100,000), then increased slightly
in 2004 (8 per 100,000).
The median age of patients was 32 years (range 15–78). Most
patients were male (79%), had low-income jobs or no jobs (60%),
and had low education levels (76%).[Table 1] Of known HIV
risk factors, 35% of patients reported that they had been clients of
a commercial sex worker (CSW) and 11% were recorded as
injection drug users. Among HIV-infected TB patients, 81%
reported having at least one HIV-related condition at the time of
HIV diagnosis.
Seven percent of HIV-infected TB patients had previously been
treated for TB. Smear-positive TB was diagnosed in 531 (83%),
smear-negative TB in 29 (5%), and extra-pulmonary TB in 77
(12%).[Table 2] Successful treatment outcomes were persistently
low, ranging from 68% to 75% for the years studied (p=0.17 for
trend).[Figure 1] For all years combined, 71% successfully
completed treatment, 1% failed, 1% defaulted, 1% transferred
out, and 26% died during TB treatment.
Risk Factors for Unsuccessful Outcomes
In bivariate analysis, we found only one factor significantly
associated (p,0.05) with an unsuccessful outcome: not being
prescribed CTX. Of 453 patients prescribed CTX, 116 (26%) had
an unsuccessful outcome compared with 33 (70%) of 47 who were
not prescribed CTX (RR 0.4; CI, 0.3–0.5).[Table 3] Data about
CTX use was missing for 133 patients; the relative risk of an
unsuccessful outcome was similar in this group as those that were
prescribed CTX. When restricting our analysis to the 47 patients
not prescribed CTX, no factors were significantly associated with
an unsuccessful outcome. Of all patients, 3 (75%) of 4 with an
adverse event had an unsuccessful outcome compared with 179
(28%) of 630 without an adverse event (Relative Risk [RR] 2.6;
95% Confidence Interval [CI] 1.5–4.7; Fisher’s exact p-
value=0.07).
In multivariate analysis, the strongly protective effect of CTX
persisted, after adjustment for sex, adverse event, rural residence,
and TB smear status.[Table 4] The protective effect of CTX
remained after re-defining all patients with missing CTX data as
having received CTX and, separately, after re-defining all patients
with missing CTX as having not received CTX. It also remained
after we repeated all three of these analyses (primary analysis,
CTX missing re-coded as received, CTX missing re-coded as not
received) comparing patients with a successful outcome to only
those that died or to those that died or defaulted, and after
removing from the model the adverse event variable, which only
occurred in a few patients.
Of the 166 patients that died, the time between treatment
initiation and death was known for 164 patients. The median time
to death was 99 days (range 4 – 470 days) (mean 111.4 days).
When stratified by CTX, the median time to death was 107 days
in persons prescribed CTX, 74 days in persons not prescribed
CTX, and 94 days in patients without known CTX status (p..05
for all comparisons). Results were similar when comparing time to
death or default (p..05 for all comparisons).
DISCUSSION
Our retrospective review of routinely collected public health data
from An Giang, Vietnam found that one in four persons with
HIV-associated TB died during treatment, but TB treatment
outcomes were significantly better in those taking CTX.
This is the first study to report an improvement in TB treatment
outcomes among HIV-infected TB patients prescribed CTX living
in Southeast Asia. Evidence for the benefit of CTX in HIV-
infected TB patients comes from a randomized, clinical trial in the
Ivory Coast, which demonstrated a 46% mortality reduction for
HIV-infected TB patients taking CTX, and subsequent observa-
tional studies in Malawi and South Africa.[11–13] Despite these
studies, a 2004 meta-analysis argued that the evidence in favor of
treating all HIV-infected TB patients with CTX was limited and
that further studies were needed.[14] Similarly, the WHO’s
Interim Policy on TB/HIV Collaborative Activities recommends
CTX for HIV-infected TB patients living in Africa, but does not
Table 2. Clinical characteristics of HIV-infected TB patients
(n=637) – An Giang, Vietnam, 2001 – 2004.
......................................................................
Characteristic Sub-category n (%)
History of TB Yes 47 (7)
No 582(93)
Smear/disease status Pulmonary, smear-positive 531 (83)
Pulmonary, smear-negative 29 (5)
Extra-pulmonary 77 (12)
Registration status New 587 (92)
Previously treated 47 (7)
Transfer in 3 (,1)
Symptoms at TB diagnosis Cough
1 605 (95)
Fever
2 447 (70)
Weight loss
3 347 (55)
Final TB treatment outcome Cure 374 (59)
Treatment completed 78 (12)
Failure 6 (1)
Died 167 (26)
Default 9 (1)
Transfer out 3 (1)
129 missing data
2188 missing data
3288 missing data
doi:10.1371/journal.pone.0000507.t002
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Figure 1. Trends in successful treatment outcomes for HIV-infected
TB patients – An Giang, Vietnam, 2001–2004.
doi:10.1371/journal.pone.0000507.g001
TB/HIV in Vietnam
PLoS ONE | www.plosone.org 4 June 2007 | Issue 6 | e507specify what should be done in other parts of the world, including
Asia.[15] This study provides some support for applying the WHO
recommendation about CTX to Vietnam.
The high mortality rate for HIV-infected TB patients in An
Giang is consistent with data from other developing countries, but
in marked contrast to the overall 92% success rate that the NTP
reports nationally for treatment of smear-positive TB.[2] In fact,
the mortality rate that we found in An Giang, and that reported
from Ho Chi Minh City, is even higher than rates reported in sub-
Saharan Africa.[4,9] The high prevalence of HIV-related condi-
tions reported by persons in this study suggests that late diagnosis
of HIV may be one cause for the high mortality rate. Also, in sub-
Saharan Africa, pulmonary, smear-negative TB is associated with
higher mortality than other forms of diagnosed TB, but we did not
find such an association in An Giang.[16] Further study is needed
to understand whether these differences are real and, if they are,
Table 3. Bivariate analysis of risk factors for unsuccessful TB treatment outcomes among HIV-infected TB patients – An Giang,
Vietnam, 2001 – 2004 (n=634).*
..................................................................................................................................................
Characteristic Sub-category Total Unsuccessful outcome, n (%) RR (95% CI)
Sex Male 500 136 (27) 0.8 (0.6–1.0)
Female 134 46 (34) Ref
Age 15–24 67 18 (27) 0.9 (0.6–1.4)
25–34 318 91 (29) Ref.
35–44 155 41 (26) 0.9 (0.7–1.3)
45–54 71 25 (35) 1.4 (0.8–2.3)
55 or older 21 6 (29) 1.0 (0.5–2.0)
Missing 2 1 (50) 1.7 (0.4–7.1)
Education Illiterate 76 22 (29) 1.0 (0.7–1.4)
Secondary school 403 121 (30) Ref.
At least high school 36 9 (25) 0.8 (0.5–1.5)
Missing 119 30 (25) 0.8 (0.6–1.2)
Marital status Married 300 85 (28) Ref.
Single 143 45 (32) 1.1 (0.8–1.5)
Divorced 32 9 (28) 1.0 (0.6–1.8)
Separated 30 10 (33) 1.2 (0.7–2.0)
Widowed 13 3 (23) 0.8 (0.3–2.2)
Missing 116 30 (26) 0.9 (0.6–1.3)
HIV risk group Men having sex with men 3 0 Undefined
Sex with commercial sex worker 221 60 (27) 0.9 (0.5–1.6)
Sex with stable partner 83 27 (323 1.2 (0.6–2.0)
Sex with multiple partner 34 10 (29) Ref.
Injection drug user 67 25 (37) 1.3 (0.7–2.3)
HIV-infected mother 11 2 (18) 0.6 (0.2–2.4)
Missing 215 58 (27) 0.9 (0.5–1.6)
Residence Urban area 165 52 (32) Ref.
Rural area 468 130 (28) 0.9 (0.7–1.2)
Missing 1 0 (0) Undefined
History of TB Yes 47 11 (23) 0.8 (0.5–1.4)
No 587 171 (29) Ref.
Sputum/disease status Pulmonary, smear-positive 528 155 (29) Ref.
Pulmonary, smear-negative 29 11 (38) 1.3 (0.8–2.1)
Extra-pulmonary 77 16 (21) 0.7 (0.5–1.1)
Prescribed co-trimoxazole Yes 454 116 (26) 0.4 (0.3–0.5)
No 47 33 (70) Ref.
Missing 133 33 (25) 0.4 (0.3–0.5)
Adverse event during TB treatment Yes 4 3 (75) 2.6 (1.5–4.7){
No 630 179 (28) Ref.
*For this analysis, patients with an end-of-treatment outcome coded as ‘‘cure’’ or ‘‘completed’’ were characterized as having a ‘‘successful’’ outcome, and those coded as
‘‘failure’’ ‘‘default’’ or ‘‘died’’ as having an ‘‘unsuccessful’’ outcome. Patients with missing data were excluded from the analysis.
{Fisher’s exact p-value=0.07.
doi:10.1371/journal.pone.0000507.t003
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PLoS ONE | www.plosone.org 5 June 2007 | Issue 6 | e507what their implications may be for responding to the TB/HIV
syndemic in Vietnam.[17]
We found two unique features about the epidemiology of HIV-
associated TB in An Giang. First, HIV-associated TB occurred
most frequently in young men who reported sex with a commercial
sex worker. The populations most at risk of acquiring HIV in
Vietnam are IDU, commercial sex workers, and clients of
commercial sex workers. Our review found that IDU comprised
only a small proportion of HIV-infected TB patients in An Giang.
Although this finding may be attributable to under-reporting, low
rates of reported IDU are plausible, because this province is
located far from large urban centers where injection drug use is
more common.[18] Second, the vast majority of cases were smear-
positive, which is uncommon in most HIV epidemic settings.
Possible explanations include: insufficient case finding for TB in
HIV-infected patients, in whom smear-negative and extra-
pulmonary TB would be more common; a high prevalence of
non-tuberculous mycobacteria; or inaccurate sputum microscopy.
Given the high mortality rate, we think it is unlikely that the high
proportion of smear-positive patients is attributable to patients
having less advanced HIV disease.
This study has several major limitations. It was retrospective
and based only on data that was available in clinical and public
health records. We could not independently verify the accuracy of
these records, nor could we collect additional data needed to
confirm or refute our findings. This impacts variables such as those
measuring the presence of an adverse event and CTX use. In
particular, we cannot differentiate between patients prescribed
CTX and patients who actually took CTX, nor can we know
whether other unmeasured factors could account for differences in
mortality rates between those taking CTX and those not taking it,
including CD4 count, opportunistic infections, malaria, and
diarrheal disease. The consistency and strength of association
between CTX in our multivariate analysis, however, is reassuring.
An Giang has implemented the core activities recommended by
WHO for responding to the TB/HIV syndemic, including HIV
counseling and testing of TB patients, TB screening for HIV
patients, and CTX preventive therapy. Nevertheless, the high
mortality rate suggests that the quality and quantity of such
activities may need to be increased and, even more important, that
activities should be expanded to include ART, which has been
demonstrated to be life-saving in HIV-infected TB patients and
possibly INH preventive therapy, which has been shown to greatly
reduce TB risk among HIV patients.[5,6] This study indicates
a major need to expand HIV-related care and treatment in An
Giang and throughout Vietnam, and Vietnam has responded to
this need by increasing HIV counseling and testing of TB patients,
TB screening in HIV patients, and ART services. Evaluating data
from these activities will help validate the findings from this study,
identify other interventions effective at reducing mortality, and
develop the critical evidence-base for responding to the TB/HIV
syndemic.
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